Roth Capital Affirms Ligand Pharma (LGND) Following Solid Q2 Revenue Results for Promacta (NVS) Jul 19, 2016 10:21AM
Roth Positive on Ligand Pharma (LGND) Amid Another Key OmniAb Collaboration (GILD) Jul 8, 2016 09:47AM
Roth Keeps Ligand Pharma (LGND) at 'Buy' as Kyprolis Receives Expanded Indication in Europe (AMGN) Jul 5, 2016 09:18AM
Orphan Drug Exclusivity for Spectrum's (SPPI) Evomela is Important Increment for Ligand (LGND) - Roth Capital Apr 20, 2016 12:37PM
Roth Remains Bullish on Ligand Pharma (LGND) as Revolade Gets Expanded Approval in Europe (NVS) Apr 7, 2016 07:56AM


Oct 23, 2015 09:18AM Roth Capital Trims PT on Ligand (LGND) to $138; Will Remove Evomela from Revenue Projections (SPPI)
Sep 2, 2015 08:38AM Ligand Pharma (LGND) Reaffirmed at 'Buy' by Roth Following European Promacta Approval, Evomela Update
Aug 17, 2015 03:28PM Roth Capital Remains Cautiously Optimistic on Spectrum Pharma (SPPI) Following Apaziquone Phase 3 SPA Agreement
Apr 8, 2015 02:51PM Notable 52-Week Highs and Lows 4/8: (ADXS) (LULU) (DG) High; (SPPI) (CEQP) Low
Apr 8, 2015 02:27PM Door Now Open for Sandoz's Generic Version of Spectrum Pharma's (SPPI) Fusilev; Roth Affirms at 'Neutral'
Mar 16, 2015 02:02PM Roth Affirms Spectrum Pharma (SPPI) at 'Neutral'; Focus Remains on Pipeline Advancement
Feb 26, 2015 02:24PM Roth Capital (SPPI) Comments on Spectrum (SPPI) Following Tentative FDA Approval of Sandoz's Levoleucovorin Calcium
Feb 23, 2015 07:01AM Roth Capital Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
Dec 26, 2014 02:43PM Roth Positive on Spectrum Pharma (SPPI) Following CE-Melphalan NDA Filing (LGND)
Sep 18, 2014 10:37AM Roth 'Encouraged' by Spectrum's (SPPI) Licensing Agreement with CASI Pharma (CASI)
Jul 7, 2014 07:20AM Roth Capital Remains Positive on Spectrum Pharma (SPPI) as Beleodaq Wins Accelerated Approval
Mar 7, 2014 08:57AM Roth Keeps Spectrum Pharma (SPPI) at Buy; Q4 Results are Speed Bump on Road to Profitability
Feb 6, 2014 10:20AM Roth Capital Reaffirms Spectrum (SPPI) at Buy; FDA Grants Beleodaq NDA Priority Review
Dec 18, 2013 07:15AM Spectrum Pharma (SPPI) Prices $100M 2.75% Covertible Notes Offering
Jan 26, 2012 10:20AM Roth Capital Upgrades Spectrum Pharmaceuticals (SPPI) to Buy
Sep 12, 2011 10:52AM Notable Analyst Rating Changes 09/12: (ORCL) (LVLT) (MON) Upgraded; (CREE) (SPPI) (NIHD) Downgraded
Sep 12, 2011 08:14AM Roth Capital Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral